Cell Line Development Capabilities Updates
-
Catalent Capabilities Update June 2026: Cell Line Development
6/24/2026
Discover how an integrated approach to transient expression, cell line development, and manufacturing can accelerate biologics development from gene to IND.
-
Avid Bioservices Capabilities Update June 2026: Cell Line Development
6/19/2026
Explore how integrated cell line development and early-stage capabilities enable faster timelines while building a strong foundation for clinical and commercial success.
-
WuXi Biologics Capabilities Update June 2026: Cell Line Development
6/19/2026
Targeted integration improves titer, stability, and consistency in cell line development, accelerating timelines, reducing risk, and enabling scalable, data-driven CMC for complex biologics.
-
Rentschler Biopharma Capabilities Update June 2026: Cell Line Development
6/19/2026
Next-gen CMC uses high-performing cell lines to accelerate timelines, improve consistency, and scale efficiently, leveraging gains in stability, pool quality, and process intensification.
-
Abzena Capabilities Update June 2026: Cell Line Development
6/16/2026
Accelerate biotherapeutic development with integrated workflows. Learn how early stable pools and advanced vectors decouple material generation from clone selection, de-risking clinical scale-up.